Press Releases TRACON Pharmaceuticals, Inc.

Equities

TCON

US89237H3084

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
1.93 ^USD	+5.46%		+3.76%	-44.89%

03/04	TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned	CI
06/03	HC Wainwright Adjusts Price Target on TRACON Pharmaceuticals to $6 From $7, Keeps Buy Rating	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024	08/05	AQ
TRACON Pharmaceuticals Announces Reverse Stock Split	08/04	AQ
TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue the Trial as Planned	03/04	AQ
Tracon: Q4 Earnings Snapshot	06/03	AQ
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update	06/03	AQ
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024	29/02	AQ
TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial	20/12	AQ
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment	20/11	AQ
Tracon: Q3 Earnings Snapshot	10/11	AQ
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update	10/11	AQ
TRACON to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 9, 2023	01/23/01	AQ
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned	18/23/18	AQ
TRACON Pharmaceuticals Announces Participation at Upcoming Investor Conferences	06/23/06	AQ
Tracon: Q2 Earnings Snapshot	15/23/15	AQ
TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update	15/23/15	AQ
TRACON to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 14, 2023	03/23/03	AQ
TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma	11/23/11	AQ
TRACON Pharmaceuticals Announces Positive Results Based on Ongoing Double-Digit Objective Response Rate for Single Agent Envafolimab in the ENVASARC Phase 2 Pivotal Trial	20/23/20	AQ
TRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conference	16/23/16	AQ
TRACON Pharmaceuticals Announces Enforcement Action to Collect Binding Arbitration Award from I-Mab Biopharma	15/23/15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases TRACON Pharmaceuticals, Inc.

Equities

TCON

US89237H3084

Press Releases

Filters